ZJYL vs. ESTA, CDRE, AVNS, SMTI, INGN, LAKE, CLGN, APT, NTRB, and MLSS
Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include Establishment Labs (ESTA), Cadre (CDRE), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT), Nutriband (NTRB), and Milestone Scientific (MLSS). These companies are all part of the "surgical appliances & supplies" industry.
Jin Medical International (NASDAQ:ZJYL) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.
In the previous week, Establishment Labs had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Establishment Labs and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.30 beat Establishment Labs' score of 0.92 indicating that Jin Medical International is being referred to more favorably in the media.
Jin Medical International has a net margin of 0.00% compared to Establishment Labs' net margin of -53.12%. Jin Medical International's return on equity of 0.00% beat Establishment Labs' return on equity.
Jin Medical International has higher earnings, but lower revenue than Establishment Labs.
Establishment Labs has a consensus price target of $55.00, indicating a potential upside of 5.30%. Given Establishment Labs' higher probable upside, analysts plainly believe Establishment Labs is more favorable than Jin Medical International.
Establishment Labs received 112 more outperform votes than Jin Medical International when rated by MarketBeat users.
72.9% of Establishment Labs shares are held by institutional investors. 11.4% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Jin Medical International has a beta of 18.8, suggesting that its stock price is 1,780% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500.
Summary
Establishment Labs beats Jin Medical International on 7 of the 12 factors compared between the two stocks.
Get Jin Medical International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jin Medical International Competitors List
Related Companies and Tools
